23 Results for "

Neuro-2a cells

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "Neuro-2a cells" in MCE Product Catalog:

49
49 Publications Verification
Cat. No.: HY-B1081A
CAS No.: 636-00-0
Synonyms: 6-Hydroxydopamine hydrobromide; 6-OHDA hydrobromide
Oxidopamine (6-OHDA) hydrobromide is an antagonist of the neurotransmitter dopamine. Oxidopamine hydrobromide is a widely used neurotoxin and selectively destroys dopaminergic neurons. Oxidopamine hydrobromide promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion. Oxidopamine hydrobromide can be used for the research of Parkinson’s disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome .
loading...
    loading...
49
49 Publications Verification
Cat. No.: HY-B1081
CAS No.: 28094-15-7
Synonyms: 6-Hydroxydopamine Hydrochloride
Oxidopamine (6-OHDA) hydrochloride is an antagonist of the neurotransmitter dopamine. Oxidopamine hydrochloride is a widely used neurotoxin and selectively destroys dopaminergic neurons. Oxidopamine hydrochloride promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion. Oxidopamine hydrochloride can be used for the research of Parkinson’s disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-151527
CAS No.: 2708177-73-3
Purity:  98.64%
Research Areas:  

Neurological Disease

PI3K/Akt/CREB activator 1 (compound AE-18) is a potent, orally active PI3K/Akt/CREB activator. PI3K/Akt/CREB activator 1 promotes neuronal proliferation, induced differentiation of Neuro-2a cells into a neuron-like morphology, and accelerated the establishment of axon-dendrite polarization of primary hippocampal neurons through upregulating brain-derived neurotrophic factor via the PI3K/Akt/CREB pathway. PI3K/Akt/CREB activator 1 can be used in research of vascular dementia (VaD) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-Y0669
CAS No.: 535-75-1
Pipecolic acid is an orally bioavailable, blood-brain barrier-permeable metabolite of lysine with antioxidant, inhibitor, and inducer activity. Pipecolic acid modulates the YAP-GPX4 signaling pathway, reduces retinal vascular tube formation, and mitigates ferroptosis. Pipecolic acid potentiates voltage-sensitive Ca 2+ channel currents and induces neuronal apoptosis. Pipecolic acid can be used for the research of diabetic retinopathy .
loading...
    loading...
Cat. No.: HY-120215
CAS No.: 1402612-64-9
Purity:  99.86%
Target:  

MAGL

Research Areas:  

Metabolic Disease

KT203 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6), with an IC50 of 0.31 nM in Neuro2A cells .
loading...
    loading...
Cat. No.: HY-120177
CAS No.: 1402612-62-7
Purity:  99.93%
Target:  

MAGL

Research Areas:  

Others

KT182 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6), with an IC50 of 0.24 nM in Neuro2A cells .
loading...
    loading...
Cat. No.: HY-115498
CAS No.: 1037837-27-6
Purity:  99.08%
ARN14494 is a potent and selective serine palmitoyltransferase (SPT) inhibitor, with an IC50 of 27.3 nM. ARN14494 affects the CNS in terms of anti-inflammation and neuroprotection. ARN14494 protects neurons from β-amyloid 1-42-induced neurotoxicity through a variety of mechanisms, including anti-oxidation, anti-apoptosis, and anti-inflammation. ARN14494 can be used for Alzheimer’s disease research .
loading...
    loading...
Cat. No.: HY-119910
CAS No.: 529507-84-4
Purity:  99.7%
Synonyms: XIB4035
Target:  

GDNF Receptor

Research Areas:  

Neurological Disease

(E)-Aminoquinol (XIB4035) is a GFRα-1 agonist. (E)-Aminoquinol has mimic neurotrophic effects of GDNF, and induces Ret autophosphorylation in Neuro-2A cells. (E)-Aminoquinol can be used for research of Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-P10397
CAS No.: 2243939-21-9
Synonyms: rALP-2, Rubisco anxiolytic-like peptide 2
Target:  

iGluR

YHIEPV (rALP-2, Rubisco anxiolytic-like peptide 2) is a potent and orally active peptide. YHIEPV shows anxiolytic effects. YHIEPV increases leptin sensitivity to exert its anti-obesity effects .
loading...
    loading...
Cat. No.: HY-139182
CAS No.: 2514-37-6
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

CAY10762 is an inhibitor of monoacylglycerol lipase (MAGL; IC50=34.1 nM). It reduces hydrogen peroxide-induced lactate dehydrogenase (LDH) release from Neuro2a cells when used at a concentration of 1 μM. CAY10762 (10 mg/kg) increases levels of 2-arachidonoyl glycerol in mouse brain.
loading...
    loading...
Cat. No.: HY-173266
Target:  

PROTACs HDAC

Research Areas:  

Neurological Disease Cancer

TO-1187 is a selective HDAC6 PROTAC degrader with a DC50 value of 5.81 nM. TO-1187 degrades HDAC6 via the ubiquitin-proteasome pathway. TO-1187 can be used in the research of multiple myeloma, neuroblastoma, and cervical cancer .

loading...
    loading...
Cat. No.: HY-114926
CAS No.: 1472640-86-0
Purity:  99.3%
Target:  

MAGL

Research Areas:  

Neurological Disease

KT185 is an orally-bioavailable, brain-penetrant and selective ABHD6 inhibitor, with an IC50 0.21 nM in Neuro2A cells .
loading...
    loading...
Cat. No.: HY-178110
CAS No.: 3028442-70-5
Research Areas:  

Cancer

HDAC6-IN-65 is a selective HDAC6 inhibitor (IC50 = 0.9 nM) and also exhibits a certain suppressive effect on HDAC3 (IC50 = 39.4 nM). HDAC6-IN-65 can induce the accumulation of α-tubulin (ac-tubulin) and acetylated histone H3 (ac-histone H3, a class I HDAC inhibition marker) in Neuro-2a cells. HDAC6-IN-65 can be used for the study of melanoma .
loading...
    loading...
Cat. No.: HY-146678
CAS No.: 2413603-15-1
Research Areas:  

Neurological Disease

HDAC6-IN-5 (compound 11b) is a potent and BBB-penetrated HDAC6 inhibitor, with an IC50 of 0.025 μM. HDAC6-IN-5 exhibits strong inhibitory activity against 1-42 self-aggregation and AChE, with IC50 values of 3.0 and 0.72 μM. HDAC6-IN-5 can enhance neurite outgrowth without significant neurotoxicity .
loading...
    loading...
Cat. No.: HY-146679
CAS No.: 2413603-10-6
Research Areas:  

Neurological Disease

HDAC6-IN-6 (compound 6a) is a potent and BBB-penetrated HDAC6 inhibitor, with an IC50 of 0.025 μM. HDAC6-IN-6 exhibits strong inhibitory activity against 1-42 self-aggregation and AChE, with IC50 values of 3.0 and 0.72 μM. HDAC6-IN-6 can enhance neurite outgrowth without significant neurotoxicity .
loading...
    loading...
Cat. No.: HY-124503
CAS No.: 1438721-51-7
Longanlactone is a natural pyrrole-lactone alkaloid that can be used as a neurotrophic agent. Longanlactone increases BDNF gene expression in neuro2a cells .
loading...
    loading...
Cat. No.: HY-126981
CAS No.: 114066-50-1
Sarasinoside B1 is a glycoside compound. Sarasinoside B1 exhibits moderate cytotoxicity against Neuro-2a and HepG2 cell lines (IC50=~5-18 μM).
loading...
    loading...
Cat. No.: HY-119910A
CAS No.: 10023-54-8
Synonyms: (E/Z)-XIB4035
Target:  

GDNF Receptor

Research Areas:  

Neurological Disease

Aminoquinol is a GFRα-1 agonist. Aminoquinol exhibits neurotrophic effects similar to GDNF and induces Ret autophosphorylation in Neuro-2A cells. Aminoquinol can be used in research related to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-119910B
CAS No.: 7195-12-2
Synonyms: (E/Z)-XIB4035 phosphate
Target:  

GDNF Receptor

Research Areas:  

Neurological Disease

Aminoquinol ((E/Z)-XIB4035) phosphate is a GFRα-1 agonist. Aminoquinol phosphate exhibits neurotrophic effects similar to GDNF and induces Ret autophosphorylation in Neuro-2A cells. Aminoquinol phosphate can be used in research related to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-119910C
CAS No.: 3653-53-0
Synonyms: (E/Z)-XIB4035 triphosphate
Target:  

GDNF Receptor

Research Areas:  

Neurological Disease

Aminoquinol ((E/Z)-XIB4035) phosphate is a GFRα-1 agonist. Aminoquinol phosphate exhibits neurotrophic effects similar to GDNF and induces Ret autophosphorylation in Neuro-2A cells. Aminoquinol phosphate can be used in research related to Parkinson's disease .
loading...
    loading...